Mantovani L, Cortesi PA, Molina M, et al. Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis. Farmeconomia. Health Economics and Therapeutic Pathways. 2024;25(1). https://doi.org/10.7175/fe.v25i1.1568